Supply of Epinephrine Auto-Injectors (Patient Kits)

The contract involves the procurement and delivery of two FDA-compliant epinephrine auto-injector patient kits under the National Stock Number 6505015990353, specifically tailored to meet Department of Defense logistics and labeling requirements. These kits are intended for military use and must adhere to strict regulatory and operational standards to ensure reliability, safety, and compatibility with DoD supply chain protocols. The equipment is governed by NAICS code 325412, indicating production in the pharmaceutical and medicinal chemical manufacturing sector, and is being acquired under a subcontract issued by the Defense Logistics Agency on behalf of the Department of Defense. The contract was posted on July 16, 2026, and is associated with the procurement reference SPE2DX25D9822 and delivery identifier SPE2D226F3041, indicating it is part of a structured DLA fulfillment process. Though the place of performance and point of contact details are not specified, the requirement is clear: the kits must be fully compliant with FDA regulations, properly labeled in accordance with DoD standards, and delivered to support readiness and medical response needs within military operations. The absence of a set-aside designation suggests the contract is open to any qualified vendor capable of meeting all technical, regulatory, and logistical specifications.